Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients...

Moderna’s stock soared by 95% in early trading on Wednesday, nearly doubling the biotech giant’s share price after the firm announced positive results from its first-ever late-stage trial of an experi...